Napp Pharmaceutical Holdings

This Cambridge company has been developing drugs to treat severe pain since the 1980s. It specialises in prolonged-release medications and says it produced the first such morphine tablets for cancer patients. The business now supplies more than 15 pain-killing medicines and has developed treatments for asthma and rheumatoid arthritis.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
CompanyNapp Pharmaceutical Holdings
ActivityPharmaceuticals maker
Sales £m*289.3
Operating profit £m*64.2
Main shareholdersSackler Family trusts (50%), Pacific Moon Corp (50%)

If applicable:

* supplied by Company   † annualised figure   ‡  profit = ebitda